Baidu
map

2020 SIN/SID联合立场声明:糖尿病患者肾脏活检的适应证

2020-11-27 意大利肾病学会 Nutr Metab Cardiovasc Dis . 2020 Nov 27;30(12):2123-2132.

2020年11月,意大利肾病学会(SIN)联合意大利糖尿病学会(SID)共同发布了糖尿病患者肾脏活检的适应证声明。文章主要回顾了糖尿病患者肾脏活检的主要适应证,鉴于糖尿病肾病的不同临床表现和并存以及相

中文标题:

2020 SIN/SID联合立场声明:糖尿病患者肾脏活检的适应证

英文标题:

Indications for renal biopsy in patients with diabetes. Joint position statement of the Italian Society of Nephrology and the Italian Diabetes Society

发布机构:

意大利肾病学会

发布日期:

2020-11-27

简要介绍:

2020年11月,意大利肾病学会(SIN)联合意大利糖尿病学会(SID)共同发布了糖尿病患者肾脏活检的适应证声明。文章主要回顾了糖尿病患者肾脏活检的主要适应证,鉴于糖尿病肾病的不同临床表现和并存以及相关异质性组织的病理学模式,更加广泛的应用肾脏活检可能对提供病因、诊断以及治疗和预后有价值的信息至关重要。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=2020 SIN_SID联合立场声明:糖尿病患者肾脏活检的适应证.pdf)] GetToolGuiderByIdResponse(projectId=1, id=05b481c00202e829, title=2020 SIN/SID联合立场声明:糖尿病患者肾脏活检的适应证, enTitle=Indications for renal biopsy in patients with diabetes. Joint position statement of the Italian Society of Nephrology and the Italian Diabetes Society, guiderFrom=Nutr Metab Cardiovasc Dis . 2020 Nov 27;30(12):2123-2132., authorId=0, author=, summary=2020年11月,意大利肾病学会(SIN)联合意大利糖尿病学会(SID)共同发布了糖尿病患者肾脏活检的适应证声明。文章主要回顾了糖尿病患者肾脏活检的主要适应证,鉴于糖尿病肾病的不同临床表现和并存以及相, cover=https://img.medsci.cn/20201223/1608737618180_2020535.jpg, journalId=0, articlesId=null, associationId=1255, associationName=意大利肾病学会, associationIntro=, copyright=0, guiderPublishedTime=Fri Nov 27 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2020年11月,意大利肾病学会(SIN)联合意大利糖尿病学会(SID)共同发布了糖尿病患者肾脏活检的适应证声明。文章主要回顾了糖尿病患者肾脏活检的主要适应证,鉴于糖尿病肾病的不同临床表现和并存以及相关异质性组织的病理学模式,更加广泛的应用肾脏活检可能对提供病因、诊断以及治疗和预后有价值的信息至关重要。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=108821, tagName=肾脏活检)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌科, tenant=100), CategoryDto(categoryId=14, categoryName=肾内科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=8690, guiderKeyword=经皮肾脏活检, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=0, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=14104, appHits=177, showAppHits=0, pcHits=458, showPcHits=13927, likes=1, shares=24, comments=11, approvalStatus=1, publishedTime=Thu Dec 24 00:58:41 CST 2020, publishedTimeString=2020-11-27, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Wed Dec 23 23:33:51 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Fri Jan 05 11:05:07 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 SIN_SID联合立场声明:糖尿病患者肾脏活检的适应证.pdf)])
2020 SIN_SID联合立场声明:糖尿病患者肾脏活检的适应证.pdf
下载请点击:
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=913905, encodeId=942b91390549, content=好声明!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Jan 05 16:43:46 CST 2021, time=2021-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913333, encodeId=662a9133337a, content=好声明!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun Jan 03 17:14:52 CST 2021, time=2021-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912225, encodeId=078d9122250c, content=很赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1cbf5448904, createdName=ms3000001417319363, createdTime=Wed Dec 30 16:35:44 CST 2020, time=2020-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911117, encodeId=c9e691111ed6, content=好声明!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sat Dec 26 19:05:58 CST 2020, time=2020-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910939, encodeId=6bd49109391e, content=已学, beContent=null, objectType=guider, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/19/425bda35e83de63900d3afe3ba2e5cd0.jpg, createdBy=53612384207, createdName=1231cf9dm12暂无昵称, createdTime=Fri Dec 25 18:05:23 CST 2020, time=2020-12-25, status=1, ipAttribution=)]
    2021-01-05 jyzxjiangqin

    好声明!

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=913905, encodeId=942b91390549, content=好声明!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Jan 05 16:43:46 CST 2021, time=2021-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913333, encodeId=662a9133337a, content=好声明!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun Jan 03 17:14:52 CST 2021, time=2021-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912225, encodeId=078d9122250c, content=很赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1cbf5448904, createdName=ms3000001417319363, createdTime=Wed Dec 30 16:35:44 CST 2020, time=2020-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911117, encodeId=c9e691111ed6, content=好声明!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sat Dec 26 19:05:58 CST 2020, time=2020-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910939, encodeId=6bd49109391e, content=已学, beContent=null, objectType=guider, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/19/425bda35e83de63900d3afe3ba2e5cd0.jpg, createdBy=53612384207, createdName=1231cf9dm12暂无昵称, createdTime=Fri Dec 25 18:05:23 CST 2020, time=2020-12-25, status=1, ipAttribution=)]
    2021-01-03 jyzxjiangqin

    好声明!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=913905, encodeId=942b91390549, content=好声明!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Jan 05 16:43:46 CST 2021, time=2021-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913333, encodeId=662a9133337a, content=好声明!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun Jan 03 17:14:52 CST 2021, time=2021-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912225, encodeId=078d9122250c, content=很赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1cbf5448904, createdName=ms3000001417319363, createdTime=Wed Dec 30 16:35:44 CST 2020, time=2020-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911117, encodeId=c9e691111ed6, content=好声明!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sat Dec 26 19:05:58 CST 2020, time=2020-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910939, encodeId=6bd49109391e, content=已学, beContent=null, objectType=guider, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/19/425bda35e83de63900d3afe3ba2e5cd0.jpg, createdBy=53612384207, createdName=1231cf9dm12暂无昵称, createdTime=Fri Dec 25 18:05:23 CST 2020, time=2020-12-25, status=1, ipAttribution=)]
    2020-12-30 ms3000001417319363

    很赞

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=913905, encodeId=942b91390549, content=好声明!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Jan 05 16:43:46 CST 2021, time=2021-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913333, encodeId=662a9133337a, content=好声明!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun Jan 03 17:14:52 CST 2021, time=2021-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912225, encodeId=078d9122250c, content=很赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1cbf5448904, createdName=ms3000001417319363, createdTime=Wed Dec 30 16:35:44 CST 2020, time=2020-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911117, encodeId=c9e691111ed6, content=好声明!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sat Dec 26 19:05:58 CST 2020, time=2020-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910939, encodeId=6bd49109391e, content=已学, beContent=null, objectType=guider, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/19/425bda35e83de63900d3afe3ba2e5cd0.jpg, createdBy=53612384207, createdName=1231cf9dm12暂无昵称, createdTime=Fri Dec 25 18:05:23 CST 2020, time=2020-12-25, status=1, ipAttribution=)]
    2020-12-26 jyzxjiangqin

    好声明!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=913905, encodeId=942b91390549, content=好声明!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Jan 05 16:43:46 CST 2021, time=2021-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913333, encodeId=662a9133337a, content=好声明!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun Jan 03 17:14:52 CST 2021, time=2021-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912225, encodeId=078d9122250c, content=很赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1cbf5448904, createdName=ms3000001417319363, createdTime=Wed Dec 30 16:35:44 CST 2020, time=2020-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911117, encodeId=c9e691111ed6, content=好声明!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sat Dec 26 19:05:58 CST 2020, time=2020-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910939, encodeId=6bd49109391e, content=已学, beContent=null, objectType=guider, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/19/425bda35e83de63900d3afe3ba2e5cd0.jpg, createdBy=53612384207, createdName=1231cf9dm12暂无昵称, createdTime=Fri Dec 25 18:05:23 CST 2020, time=2020-12-25, status=1, ipAttribution=)]
    2020-12-25 1231cf9dm12暂无昵称

    已学

    0

Baidu
map
Baidu
map
Baidu
map